Myrexis, Inc. (MYRX)

[Special Situations]

ENZN NOL: $100+M


ENZN - Enzon Pharmaceuticals, Inc.

FORM 10-K (For the Fiscal Year Ended December 31, 2019).

https://www.sec.gov/Archives/edgar/data/727510/000110465920022802/tm205379-1_10k.htm


"At December 31, 2019, the Company had federal net operating loss carryforwards of approximately $101.6 million, of which approximately $100.6 million will expire in the years 2025 through 2036, and New Jersey state net operating loss carryforwards of approximately $23.9 million that expire in the years 2031 through 2039."